Journal profile · Medicine-Biochemistry (medical)
Advances in Biomarker Sciences and Technology
ISSN 2543-1064 · KeAi Communications Co. Ltd. · China
Advances in Biomarker Sciences and Technology: fully open access; APC about USD 700; review about 20 weeks (community reports); 42 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Advances in Biomarker Sciences and Technology is published by KeAi Communications Co. Ltd.. By OpenAlex counts of its recent articles, its largest topics are MicroRNA in disease regulation, Gut microbiota and health and Essential Oils and Antimicrobial Activity, together about 20.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Advances in Biomarker Sciences and Technology (ABST) is a rigorously peer-reviewed, fully open access journal that aims to encompass all aspects of biomarker research, from biomarker development to its applications, clinical diagnosis and treatment to molecular epidemiology and toxicology; from precision medicine to drug development, and from nanotechnology to bioinformatics. ABST focuses on building upon the next generation of biomarkers to accelerate communication of the latest advances in their identification as well as applications. We strive to achieve this objective by providing a high-quality forum for the publication of biomarker-related investigations, including (but not limited to) general research articles elucidating topics in novel technologies, study designs or mathematical models, invited and selected reviews, short communications and editorials. Editorial Board
From the journal's Aims & Scope
Research area (LetPub): Medicine-Biochemistry (medical)
Editor-in-chief Luoping Zhang DivisionPublisher website
Editorial board by country: 25 in mainland China (about 52%); most named Mainland China 25, United States 11, Hong Kong, China 2, United Kingdom 2, Italy 2 (48 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology8.3%
- Gut microbiota and healthBiochemistry, Genetics and Molecular Biology6.3%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences6.3%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology6.3%
- COVID-19 Clinical Research StudiesMedicine5.2%
- Computational Drug Discovery MethodsComputer Science4.2%
- Liver Disease Diagnosis and TreatmentMedicine4.2%
- Metabolomics and Mass Spectrometry StudiesBiochemistry, Genetics and Molecular Biology4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 3.1LetPub ·
- CiteScore (publisher)
- 3.1Publisher website ·
- SJR 2026-06
- 0.34LetPub ·
- SNIP 2026-06
- 0.5LetPub ·
- h-index
- 13OpenAlex ·
- i10-index
- 17OpenAlex ·
- 2-year mean citedness
- 2.26OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 134 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 40 | 40 | 26 |
| 2025 | 42 | 42 | 107 |
| 2024 | 26 | 26 | 111 |
| 2023 | 13 | 13 | 45 |
| 2022 | 4 | 4 | 75 |
| 2021 | 2 | 2 | 19 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 20 weeksLetPub ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 700 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 700 | — | — | |
| LetPub | USD 700 | Yes | — | |
| Publisher website | USD 700 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 3
- Reference style
- AMA
- Highlights
- Optional
Article types accepted10
- articleArticle, Review, Short Communication, Microarticle, Opinion, Practice Guidelines, Technical Note, Original Software Publication, Editorial, CorrespondenceLength not stated
- correspondenceArticle, Review, Short Communication, Microarticle, Opinion, Practice Guidelines, Technical Note, Original Software Publication, Editorial, CorrespondenceLength not stated
- editorialArticle, Review, Short Communication, Microarticle, Opinion, Practice Guidelines, Technical Note, Original Software Publication, Editorial, CorrespondenceLength not stated
- microarticleArticle, Review, Short Communication, Microarticle, Opinion, Practice Guidelines, Technical Note, Original Software Publication, Editorial, CorrespondenceLength not stated
- opinionArticle, Review, Short Communication, Microarticle, Opinion, Practice Guidelines, Technical Note, Original Software Publication, Editorial, CorrespondenceLength not stated
- original software publicationArticle, Review, Short Communication, Microarticle, Opinion, Practice Guidelines, Technical Note, Original Software Publication, Editorial, CorrespondenceLength not stated
- practice guidelinesArticle, Review, Short Communication, Microarticle, Opinion, Practice Guidelines, Technical Note, Original Software Publication, Editorial, CorrespondenceLength not stated
- reviewArticle, Review, Short Communication, Microarticle, Opinion, Practice Guidelines, Technical Note, Original Software Publication, Editorial, CorrespondenceLength not stated
- short communicationArticle, Review, Short Communication, Microarticle, Opinion, Practice Guidelines, Technical Note, Original Software Publication, Editorial, CorrespondenceLength not stated
- technical noteArticle, Review, Short Communication, Microarticle, Opinion, Practice Guidelines, Technical Note, Original Software Publication, Editorial, CorrespondenceLength not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Plagiarism, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper. Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use. Authors preparing a manuscript for this journal may use AI to…
Source ↗Publisher website ·- Authorship Authorship
All authors should have made substantial contributions to all of the following: The conception and design of the study, or acquisition of data, or analysis and interpretation of dataDrafting the article or revising it critically for important intellectual content.Final approval of the version to be submitted. All authors are accountable for all aspects of the work, to ensure that questions related…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include: EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board…
Source ↗Publisher website ·- License & copyright Creative Commons Attribution (CC BY)
Allows users to: distribute and copy the article; create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation); include in a collective work (such as an anthology); and text or data mine the article. These uses are permitted even for commercial purposes, provided the user: gives appropriate credit to the author(s) (with a lin…
Source ↗Publisher website ·- Open access KeAi Guide for authors: Open Access
This is an open access journal: all articles will be immediately and permanently free for everyone to read and download. To provide open access, this journal has an open access fee (also known as an article publishing charge APC) which needs to be paid by the authors or on their behalf e.g. by their research funder or institution. Permitted third party (re)use is defined by the following Creative …
Source ↗Publisher website ·- Peer review Peer review
single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors to determine suitability for publication in this journal. If your submission is deemed suitable, it will typically be sent to a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected will…
Source ↗Publisher website ·- Plagiarism
iThenticate CrossCheck plagiarism screening Model summary
Submissions to KeAi journals are automatically screened using iThenticate's CrossCheck within the editorial system to detect plagiarism issues including instances of overlapping and similar text in submitted manuscripts.
Source ↗Publisher website ·- Preprints Preprint sharing
preprint sharing allowed Model summary
Authors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication. We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- KeAi Communications Co. Ltd.
- Country or region
- China
- Language
- English
- ISSN
- 2543-1064
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Advances in Biomarker Sciences and Technology
How long does peer review take at Advances in Biomarker Sciences and Technology?
Authors report an average review time of about 20 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Advances in Biomarker Sciences and Technology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 3; Reference style: AMA; Highlights: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Advances in Biomarker Sciences and Technology based?
Of the 48 board members whose country the journal's board page names, 25 (about 52%) are in mainland China; the countries named most often are Mainland China (25), United States (11) and Hong Kong, China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Advances in Biomarker Sciences and Technology?
According to LetPub and DOAJ records, Advances in Biomarker Sciences and Technology is indexed in Scopus and DOAJ.
Is Advances in Biomarker Sciences and Technology open access, and what is the APC?
Advances in Biomarker Sciences and Technology is a fully open-access journal. APC about USD 700.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .